Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Jan;44(1):16-20.
doi: 10.1007/BF01630481.

Effects of topical antiinflammatory agents on Freund's adjuvant-induced skin lesions in rats

Affiliations

Effects of topical antiinflammatory agents on Freund's adjuvant-induced skin lesions in rats

G J Gendimenico et al. Inflamm Res. 1995 Jan.

Abstract

Freund's adjuvant, when administered intradermally to rats, causes polyarthritis as well as inflammation of the skin, eye, gastrointestinal and genitourinary tracts. We assessed the effects of antiinflammatory drugs on ear skin lesions to determine if this might be a useful skin inflammation model. The hind paw of male Lewis rats was injected with Mycobacterium butyricum in paraffin oil. Lesions appeared between days 13 and 15 after adjuvant injection. Each ear exhibited on average 1 to 3 highly erythematous, elevated lesions, 2 to 3 mm in diameter. By histology, the lesions consisted of epidermal hyperplasia, with a prominent accumulation of inflammatory cells in the dermis. Ears were treated topically with glucocorticoids, cyclosporine and indomethacin on days 15 through 21 after adjuvant injection. By day 22, dexamethasone, fluocinolone acetonide, and cyclosporine caused near-complete clearing of lesions whereas indomethacin exacerbated the inflammation by causing increased numbers of skin lesions. These results show the potential usefulness of adjuvant-induced skin lesions in rats as a novel subchronic inflammation model.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Invest Dermatol. 1994 Jan;102(1):128-37 - PubMed
    1. Br J Dermatol. 1988 Feb;118(2):183-90 - PubMed
    1. Biochem Pharmacol. 1988 Sep 15;37(18):3511-4 - PubMed
    1. Agents Actions. 1989 Mar;26(3-4):335-41 - PubMed
    1. Agents Actions. 1985 Dec;17(2):197-204 - PubMed